Načítá se...
MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis in vitro and in vivo
Neuroblastoma (NB) is responsible for 15% of all childhood cancer deaths. Despite advances in treatment and disease management, the overall 5-year survival rates remain poor in high-risk disease (25–40%). It is well known that miR-145 functions as a tumor suppressor in several types of cancer. Howev...
Uloženo v:
| Vydáno v: | Bioengineered |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039631/ https://ncbi.nlm.nih.gov/pubmed/32083506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21655979.2020.1729928 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|